Alumis Inc. Files 8-K: Other Events & Financials
Ticker: ALMS · Form: 8-K · Filed: Mar 10, 2025 · CIK: 1847367
| Field | Detail |
|---|---|
| Company | Alumis Inc. (ALMS) |
| Form Type | 8-K |
| Filed Date | Mar 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-events, financials
TL;DR
Alumis Inc. filed an 8-K on March 10, 2025, covering other events and financial statements.
AI Summary
Alumis Inc. filed an 8-K on March 10, 2025, reporting other events and financial statements/exhibits as of March 8, 2025. The company, formerly Esker Therapeutics, Inc., is incorporated in Delaware and headquartered in South San Francisco, California.
Why It Matters
This filing indicates Alumis Inc. is providing updates on its corporate activities and financial status, which is important for investors to monitor company developments.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, typically used for significant corporate events or financial updates, and does not inherently signal high risk.
Key Players & Entities
- Alumis Inc. (company) — Registrant
- Esker Therapeutics, Inc. (company) — Former company name
- March 8, 2025 (date) — Earliest event reported date
- March 10, 2025 (date) — Date of report
- 280 East Grand Avenue South San Francisco, California 94080 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Alumis Inc.?
The 8-K filing reports on 'Other Events' and 'Financial Statements and Exhibits' as of March 8, 2025.
When was the earliest event reported in this filing?
The earliest event reported was on March 8, 2025.
What is Alumis Inc.'s principal executive office address?
Alumis Inc.'s principal executive offices are located at 280 East Grand Avenue, South San Francisco, California 94080.
Has Alumis Inc. operated under any previous names?
Yes, Alumis Inc. was formerly known as Esker Therapeutics, Inc. and FL2021-001, Inc.
What is Alumis Inc.'s state of incorporation and fiscal year end?
Alumis Inc. is incorporated in Delaware and its fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 10, 2025 regarding ALUMIS INC. (ALMS).